Dermaceuticals & Clean Cosmetics
Science-backed skin formulations — from atopic dermatitis and vitiligo to anti-ageing and acne.
A portfolio of clinically-grounded dermal formulations that sit at the intersection of pharmaceutical performance and cosmetic elegance.
Exacalm® is a flagship topical product based on a novel micellar technology (patent filed), designed for hydration, atopic dermatitis, periocular itching, and skin brightening. In studies, it performed significantly better than two marketed topical steroid products on inflammation, redness, and related biomarkers.
Additional platforms include a postbiotic-silt and essential-oil bigel for restoring skin barrier function and reducing chronic itching in atopic dermatitis; a patented nanovesicular delivery system for bimatoprost as a repurposed melanogenesis stimulator in vitiligo; SLN-based anti-acne and anti-pigmentation systems for retinoids; CBD and full-spectrum cannabis SLN creams for atopic dermatitis; antimelasma serums with nanotranexamic acid; and a novel biphasic bead-in-gel moisturising system.
A physiologically compatible vaginal lubricating hydrogel — fertility-compatible, maintaining appropriate pH and osmolarity — rounds out the portfolio.
Patents
- 381031 — Topical nanoformulation of tetrahydrocurcumin (India, granted 2021)
- 354336 — Topical tazarotene solid lipid nanoparticles (India, granted 2020)
- 417693 — Topical curcumin formulation (India, granted 2023)
- 202411105055 — Emulsified Lipidic Systems for hydrophilic and hydrophobic actives (India, filed 2024)
- PCT/IN2025/050119 — Nanomicellar Composition for High Permeation (PCT, filed 2025)